However, restoring GIP efficacy in T2DM patients is possible: preclinical and clinical studies show that this can be achieved with the enhancement of hyperglycemia due to drugs [39,40] or weight loss [41]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.